Varicosclerotherapy foam sclerotherapy

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 21.03.2022

Dieser Artikel auf Deutsch

Synonym(s)

foam sclerotherapy; Foam sclerotherapy; Microfoam therapy; Varix foaming

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Procedure for sclerosing varicose veins with foamed sclerosants. Compared to liquid sclerotherapy, foam is more effective with an almost identical side effect profile. The advantage of foam sclerotherapy is the good visualization of the foam in duplex sonography.

General definitionThis section has been translated automatically.

After injection of the foam, the foamed sclerosing agent remains for a longer period of time locally in the vein section to be sclerosed and leads to a stronger sclerosing effect due to the displacement of blood and the resulting slower dilution. Therefore, venous sclerosis can be achieved with less concentrated sclerosing agents than with liquid sclerosing. Other advantages are the lower number of injections per session and the lower recurrence rate. In sclerosing large veins, a single puncture site is often sufficient for application.

IndicationThis section has been translated automatically.

  • approved indication varicose veins. Mainly for the treatment of larger or large-calibre varicose veins and for recurrent varicoses.
  • off label but also successful use in seroma and malformations.

ImplementationThis section has been translated automatically.

Foam production:

  • Technique according to Monfreux (comparatively rarely used): By retracting the plunger in a glass syringe which is tightly closed at the front, a vacuum is created which leads to an inflow of air, resulting in a coarse-bubbled, rather liquid foam.
  • Tessari technique (frequently used method): By turbulent mixing of liquid and air in two syringes connected by a 3-way cock, a foam quality is produced which is liquid in low concentrations of the sclerosing agent and more viscous in higher concentrations. The mixing ratio of sclerosing agent to air is 1:4-5.
  • Double syringe system (DSS system; frequently used method): Polidocanol is mixed with air in a sclerosing agent to air ratio of 1:5 by turbulent mixing in two syringes connected by a connector. The product is a fine bubbled, rather viscous foam.
  • Spider veins/small lumen veins: Application of liquid sclerosing agents or liquid foams, viscous foams are not indicated here. Max. 0.5 ml foam per injection
  • The foam must be produced immediately before injection.

Injection:

  • The puncture/injection should be duplex controlled.
  • The injection should be carried out lying down! It is not necessary to elevate the leg (in the past this was propagated). The application can be done via direct puncture or via a catheter, if necessary in combination with an endoluminal thermal procedure (e.g. radio wave).
  • According to the European consensus conference, a maximum amount of 10ml of foam should not be exceeded per session. Larger foam quantities lead to a higher rate of neurological and thrombotic complications. The amount of foam to be applied depends on the diameter of the vein to be treated - the larger the diameter, the more volume is required. The larger the required volume, the more viscous the foam should be.
  • Impression of the crosses with the duplex head when foam sclerosing a truncal vein is outdated.
  • After foam sclerotherapy of large varicose veins, a higher percentage of patients experience vasospasm of the sclerosed vein (positive correlation between spasm and good therapy results).

Aftercare:

  • Before applying compression, it is advisable to wait a few minutes in order to avoid premature displacement of the sclerosing foam to other regions.

Undesirable effectsThis section has been translated automatically.

S.u. Sclerotherapy.

  • Special features of foam sclerotherapy in comparison to liquid sclerotherapy - more frequent:
    • passagere neurological deficits, especially migraine headaches and visual disturbances
    • Hyperpigmentations
  • Cave! Danger of sclerosing foam rising and penetration into the deep vein system exists if used improperly!

  • Notice! Foam sclerotherapy belongs in the hands of phlebologically trained physicians experienced in sclerotherapy.

ContraindicationThis section has been translated automatically.

the contraindications for sclerotherapy in general apply. For foam sclerotherapy additionally:

  • known open Foramen ovale

PreparationsThis section has been translated automatically.

  • Active substance Polidocanol, trade name Aethoxysklerol: In Germany Polidocanol in liquid and foamed form is approved as sclerosing agent. In other countries the use is off-label.
  • Sodium tetradecyl sulphate, trade name Sotradecol (USA), Thrombovar (France): foamed application is off-label

LiteratureThis section has been translated automatically.

  • Cabrera J et al (2003) Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139: 1409-1416
  • Guidelines of the German Society of Phlebology (DGP) (2003) AWMF Guidelines Register No. 037/015
  • McAusland S (1939) The modern treatment of varicose veins. Med Press Circular 201: 404-410
  • Orbach EJ (1944) Sclerotherapy of varicose veins. Utilization of an intravenous air block. On J Surg LXVI: 362-366
  • Reich-Schupke S et al. (2008) Foam sclerosing metaanlysis of the studies. Vasomed 20: 22-23
  • Reich-Schupke S (2010) Treatment of varicose tributaries with sclerotherapy with polidocabol 0.5% foam. Vasa 39:169-174.
  • Reich-Schupke S et al (2013) Foam sclerotherapy with enoxaparin prophylaxis in high-risk patients with postthrombotic syndrome. Vasa 42:50-55.

TablesThis section has been translated automatically.

Indication

Polidocanol concentration (%)

Polidocanol-air mixing ratio

Volume (ml)

stem varices and large side branch varices > 5 mm

3-4

1:5 (1:4)

2-3 per injection/ 6-8 per session

Side branch varices > 5 mm

2-3

1:5 (1:4)

1-2 per injection

Side branch varices < 5 mm

1-2

1:4 (1:3)

0.5-1 per injection

Reticular varices < 3 mm

0,5-1

1:3

< 0.5 per injection

Spider veins

0,025-0,5

1:2 (1:3)

0.1-0.2 per injection

Authors

Last updated on: 21.03.2022